REVB FY 2020 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

-$2M

EPS (Diluted)

$-9032.69

Cash Flow

Operating Cash Flow

-$215,074

Free Cash Flow

-$215,070

Stock-Based Comp.

$43,848

Balance Sheet

Total Assets

$5M

Total Liabilities

$1M

Stockholders' Equity

$3M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$4M	-$3,638	-104238.1%
Net Income	-$2M	-$3,638	-44718.6%